Skip to main navigation Skip to search Skip to main content

Neurodevelopmental Outcomes for Individuals With Congenital Heart Disease: Updates in Neuroprotection, Risk-Stratification, Evaluation, and Management: A Scientific Statement From the American Heart Association

  • Erica Sood
  • , Jane W. Newburger
  • , Julia Anixt
  • , Adam R. Cassidy
  • , Jamie L. Jackson
  • , Richard A. Jonas
  • , Amy J. Lisanti
  • , Keila Natilde Lopez
  • , Shabnam Peyvandi
  • , Bradley S. Marino
  • Harvard University
  • Boston Children's Hospital
  • University of Cincinnati
  • Ohio State University
  • Children's National Medical Center
  • George Washington University
  • The Children's Hospital of Philadelphia
  • University of Pennsylvania
  • Baylor College of Medicine
  • University of California at San Francisco
  • Cleveland Clinic Foundation
  • Children's Memorial Hospital
  • Northwestern University
  • Cleveland Children’s Clinic

Research output: Contribution to journalReview articlepeer-review

203 Scopus citations

Abstract

Over the past decade, new research has advanced scientific knowledge of neurodevelopmental trajectories, factors that increase neurodevelopmental risk, and neuroprotective strategies for individuals with congenital heart disease. In addition, best practices for evaluation and management of developmental delays and disorders in this high-risk patient population have been formulated based on literature review and expert consensus. This American Heart Association scientific statement serves as an update to the 2012 statement on the evaluation and management of neurodevelopmental outcomes in children with congenital heart disease. It includes revised risk categories for developmental delay or disorder and an updated list of factors that increase neurodevelopmental risk in individuals with congenital heart disease according to current evidence, including genetic predisposition, fetal and perinatal factors, surgical and perioperative factors, socioeconomic disadvantage, and parental psychological distress. It also includes an updated algorithm for referral, evaluation, and management of individuals at high risk. Risk stratification of individuals with congenital heart disease with the updated categories and risk factors will identify a large and growing population of survivors at high risk for developmental delay or disorder and associated impacts across the life span. Critical next steps must include efforts to prevent and mitigate developmental delays and disorders. The goal of this scientific statement is to inform health care professionals caring for patients with congenital heart disease and other key stakeholders about the current state of knowledge of neurodevelopmental outcomes for individuals with congenital heart disease and best practices for neuroprotection, risk stratification, evaluation, and management.

Original languageAmerican English
Pages (from-to)E997-E1022
JournalCirculation
Volume149
Issue number13
DOIs
StatePublished - 26 Mar 2024

Keywords

  • Algorithms
  • American Heart Association
  • Child
  • Female
  • Heart Defects, Congenital/complications
  • Humans
  • Neuroprotection
  • Pregnancy
  • Risk Factors
  • United States

Fingerprint

Dive into the research topics of 'Neurodevelopmental Outcomes for Individuals With Congenital Heart Disease: Updates in Neuroprotection, Risk-Stratification, Evaluation, and Management: A Scientific Statement From the American Heart Association'. Together they form a unique fingerprint.

Cite this